檢索結果 - Cheng, Chung-Wei
- Showing 1 - 20 results of 67
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 tria... 由 James Cheng‐Chung Wei, Tae‐Hwan Kim, Mitsumasa Kishimoto, Naoki Ogusu, Haeyoun Jeong, S Kobayashi
出版 2021Artigo -
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
相關主題
Medicine
Internal medicine
Disease
Pathology
Ankylosing spondylitis
Alternative medicine
Confidence interval
Placebo
Physical therapy
Hazard ratio
Cohort
Environmental health
Population
Cohort study
Immunology
Psoriatic arthritis
Spondylitis
Randomized controlled trial
Axial spondyloarthritis
Sacroiliitis
Surgery
Adverse effect
Dermatology
Diabetes mellitus
Endocrinology
Proportional hazards model
Rheumatoid arthritis
Engineering
Psoriasis
Arthritis